Literature DB >> 26696299

Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation.

Nam D Tran1, Lusine Aghajanova2, Chia-Ning Kao2, Marcelle I Cedars2, Mitchell P Rosen2.   

Abstract

OBJECTIVE: To investigate the potential influence of short-term pituitary suppression on antral follicle count (AFC) and correlate the AFC with the number of oocytes retrieved after ovarian stimulation.
DESIGN: Retrospective study.
SETTING: University fertility center. PATIENT(S): A total of 1,479 infertile patients. INTERVENTION(S): Patients had baseline AFC, when they were not on any medications known to cause pituitary suppression, and follow-up AFC (suppressed AFC) while on E2, GnRH agonist (GnRH-a), oral contraceptive (OC) pills, or OC pills/GnRH-a in preparation for ovarian stimulation, performed within 6 months of initial baseline AFC. MAIN OUTCOME MEASURE(S): The AFC at baseline, AFC during pituitary suppression, and the number of oocytes retrieved. RESULT(S): Although there was an average unadjusted decline of 0.4, 0.9, 2.2, and 3.0 in AFC while patients were on E2, GnRH-a, OC pills, and OC pills/GnRH-a, respectively, this decline was driven by age, baseline AFC, and the hormones used. Although baseline and suppressed AFC were found to be good predictors of the number of oocytes retrieved after ovarian stimulation, statistically, suppressed AFC was found to be a marginally better predictor. CONCLUSION(S): Short-term pituitary suppression has a negative impact on AFC. This decline in AFC may influence the number of oocytes retrieved, suggesting the suppressive impact of exogenous hormones on the biological capacity of the ovary during stimulation.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pituitary suppression; antral follicle count; oocyte number

Mesh:

Substances:

Year:  2015        PMID: 26696299     DOI: 10.1016/j.fertnstert.2015.11.033

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  mTOR inhibitor sirolimus negatively impacts in vitro fertilization outcomes.

Authors:  Kaitlyn Wald; Hakan Cakmak; Martha Noel
Journal:  J Assist Reprod Genet       Date:  2019-03-25       Impact factor: 3.412

2.  Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.

Authors:  Joseph M Letourneau; Hakan Cakmak; Molly Quinn; Nikita Sinha; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-07-01       Impact factor: 3.412

3.  Ovarian stimulation for fertility preservation in an oncology patient with etonogestrel implant in place.

Authors:  John S Rushing; Leslie Appiah; Alex J Polotsky; Shona Murray; Erin Foust; Kathryn Hassell; Cassandra Roeca
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

4.  Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies.

Authors:  Fernanda A Correa; Paulo H M Bianchi; Marcela M Franca; Aline P Otto; Rodrigo J M Rodrigues; Dani Ejzenberg; Paulo C Serafini; Edmundo Chada Baracat; Rossana P V Francisco; Vinicius N Brito; Ivo J P Arnhold; Berenice B Mendonca; Luciani R Carvalho
Journal:  J Endocr Soc       Date:  2017-09-29

5.  Evidence of profound ovarian suppression on combined hormonal contraception resulting in dramatically different ovarian reserve testing and oocyte retrieval outcomes: case report and review of the literature.

Authors:  Chelsea W Fox; Jamie Stanhiser; Alexander M Quaas
Journal:  F S Rep       Date:  2020-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.